This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotechrss

Market Bottom Closer Than It Appears

The current market maelstrom could be nearing an end with investor capitulation close-at-hand, said Ronald Sanchez, chief investment officer of Fiduciary Trust Company International.

02/11/16 - 05:12 PM EST

Epizyme Execs Pocket Cheap Stock Options, Tone Deaf to Shareholder Pain

  • Tickers in this article:
  • EPZM

With new stock option grants this week, Epizyme executives are sending an ugly message to aggrieved shareholders: We don't mind profiting from your pain.

02/11/16 - 12:00 PM EST

5 Money Lessons Ghostface Killah Taught Pharma-Bro Martin Shkreli

5 Money Lessons Ghostface Killah Taught Pharma-Bro Martin Shkreli

Turing's Martin Shkreli picked a fight with the Wu-Tang Clan rapper and got a blistering and didactic video in response.

02/11/16 - 10:09 AM EST

Epizyme Execs Pocket Cheap Stock Options, Tone Deaf to Shareholder Pain

Epizyme Execs Pocket Cheap Stock Options, Tone Deaf to Shareholder Pain

  • Tickers in this article:
  • EPZM

With new stock option grants this week, Epizyme executives are sending an ugly message to aggrieved shareholders: We don't mind profiting from your pain.

02/11/16 - 12:00 PM EST

Incyte Falls on Jakafi Solid-Tumor Setback

Incyte Falls on Jakafi Solid-Tumor Setback

  • Tickers in this article:
  • INCY
  • NVS

Incyte is halting all clinical trials intended to expand the use of its blood cancer drug Jakafi into solid tumors due to an insufficient level of efficacy.

02/11/16 - 09:32 AM EST

3 Top Value Stocks From a Market Beating Manager

3 Top Value Stocks From a Market Beating Manager

Spectra Energy Partners is down over 23% in the past year, but the worst is likely behind both the pipeline player and natural gas prices.

02/10/16 - 10:43 AM EST

Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold For Himself

Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold For Himself

  • Tickers in this article:
  • CTIC

In the latest blowup, excess patient deaths forced CTI Bio to yank a new drug application for the myelofibrosis drug pacritinib.

02/10/16 - 08:28 AM EST

Northwest Bio Blames Short Sellers, Not Warning From Expert Doctor, for Stock Plunge

Northwest Bio Blames Short Sellers, Not Warning From Expert Doctor, for Stock Plunge

  • Tickers in this article:
  • NWBO

Frank comments and a warning from a doctor supervising pivotal brain cancer vaccine study for Northwest Bio are likely cause of sharp slide in stock price.

02/09/16 - 10:00 AM EST

6 Medical Device Stocks to Treat the Bear Market Blues

6 Medical Device Stocks to Treat the Bear Market Blues

Looking for safe growth opportunities in this dangerous, volatile market? Consider these highly promising stocks in the booming medical device industry.

02/08/16 - 04:08 PM EST

Midday Report: Chesapeake Energy Tanks; Stocks Extend Selloff

Midday Report: Chesapeake Energy Tanks; Stocks Extend Selloff

U.S. stocks picked up where they left off last week, extending a sharp selloff on Monday on worries over oil and disappointing earnings.

02/08/16 - 11:59 AM EST

Fasten Your Seatbelts: More Craziness in the Week Ahead

Fasten Your Seatbelts: More Craziness in the Week Ahead

The New Hampshire slugfest, China's week-long break for 'The Year of the Monkey,' Janet Yellen's grilling before Congress ... buckle-up for another bumpy ride in the week ahead.

02/07/16 - 07:12 PM EST

Closing Bell: Netflix Falls on Analyst Call; Tech, Biotech Slump

Closing Bell: Netflix Falls on Analyst Call; Tech, Biotech Slump

U.S. stocks ended near session lows as Wall Street suffered a market-wide selloff on Friday.

02/05/16 - 04:27 PM EST

Gilead's Glory Days Are Over -- Here's Why You Should Dump the Stock

Gilead's Glory Days Are Over -- Here's Why You Should Dump the Stock

  • Tickers in this article:
  • GILD

This once high-flying biotech stock has hit bad times that aren't likely to abate anytime soon. Here are the reasons for shunning this erstwhile Wall Street darling.

02/05/16 - 03:16 PM EST

Four European Stocks Set to Take Off in 2016

Four European Stocks Set to Take Off in 2016

Shares of Siemens dropped over 14% in 2015, but a recent earnings report has given the German turbine-maker’s stock a jolt.

02/04/16 - 12:10 PM EST

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%
Top Rated Stocks Top Rated Funds Top Rated ETFs